Stock Track | Vaxcyte Soars 5.09% Intraday on Multiple Analyst Price Target Increases

Stock Track02-25

Vaxcyte, Inc. (PCVX) saw its stock price soar 5.09% during intraday trading on Wednesday, driven by positive analyst sentiment.

The rally followed announcements from multiple investment firms raising their price targets for the biotechnology company. TD Cowen increased its target to $75 from $50 while maintaining a Buy rating, and Leerink Partners raised its target to $82 from $77. These upward revisions reflect growing analyst optimism about Vaxcyte's prospects in the healthcare sector.

Such analyst actions typically signal confidence in a company's future performance and can influence investor sentiment, leading to increased buying activity as seen in today's trading session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1149001346?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-25 22:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1149001346","market":"nz","top_or_hot":-1,"title":"Stock Track | Vaxcyte Soars 5.09% Intraday on Multiple Analyst Price Target Increases","media":"Stock Track","content":"<p>Vaxcyte, Inc. (PCVX) saw its stock price soar 5.09% during intraday trading on Wednesday, driven by positive analyst sentiment.</p><p>The rally followed announcements from multiple investment firms raising their price targets for the biotechnology company. TD Cowen increased its target to $75 from $50 while maintaining a Buy rating, and Leerink Partners raised its target to $82 from $77. These upward revisions reflect growing analyst optimism about Vaxcyte's prospects in the healthcare sector.</p><p>Such analyst actions typically signal confidence in a company's future performance and can influence investor sentiment, leading to increased buying activity as seen in today's trading session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Vaxcyte Soars 5.09% Intraday on Multiple Analyst Price Target Increases</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Vaxcyte Soars 5.09% Intraday on Multiple Analyst Price Target Increases\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-25 22:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaxcyte, Inc. (PCVX) saw its stock price soar 5.09% during intraday trading on Wednesday, driven by positive analyst sentiment.</p><p>The rally followed announcements from multiple investment firms raising their price targets for the biotechnology company. TD Cowen increased its target to $75 from $50 while maintaining a Buy rating, and Leerink Partners raised its target to $82 from $77. These upward revisions reflect growing analyst optimism about Vaxcyte's prospects in the healthcare sector.</p><p>Such analyst actions typically signal confidence in a company's future performance and can influence investor sentiment, leading to increased buying activity as seen in today's trading session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PCVX","symbol_name":"Vaxcyte, Inc.","start_time":0,"source_url":"","article_id":"1149001346","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1149001346","pubTimestamp":1772031444,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Vaxcyte, Inc. (PCVX) saw its stock price soar 5.09% during intraday trading on Wednesday, driven by positive analyst sentiment.The rally followed announcements from multiple investment firms raising...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PCVX":"Vaxcyte, Inc."},"translate_title":"个股追踪|多位分析师上调目标价Vaxcyte盘中大涨5.09%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PCVX":1},"content_text":"Vaxcyte, Inc. (PCVX) saw its stock price soar 5.09% during intraday trading on Wednesday, driven by positive analyst sentiment.The rally followed announcements from multiple investment firms raising their price targets for the biotechnology company. TD Cowen increased its target to $75 from $50 while maintaining a Buy rating, and Leerink Partners raised its target to $82 from $77. These upward revisions reflect growing analyst optimism about Vaxcyte's prospects in the healthcare sector.Such analyst actions typically signal confidence in a company's future performance and can influence investor sentiment, leading to increased buying activity as seen in today's trading session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1149001346","isCrawlerRequest":true}